Research articles
ScienceAsia 49 (2023):ID 497-506 |doi:
10.2306/scienceasia1513-1874.2023.041
Shikonin inhibits ER stress in vascular endothelial cells, when induced by H2O2, and promotes vascular regeneration
Lili Guoa,?, Yinling Lib,c,?, Shuang Wenb, Wen jun Liud, Lei Yanga, Yu Wana, Jia xin Liua, Wen e Zhaoe,*, Shu-Wei Lia,*
ABSTRACT: Shikonin is a naphthoquinone compound. Various reports proved that shikonin not only has anticancer
and antibacterial effects, but also can play a certain role in promoting wound healing. However, whether shikonin can
reduce oxidative stress degree in endothelial cells of vascular and reconstruct the lining of damaged vessels is unknown.
Therefore, we used a variety of biological techniques to study the function of shikonin in protecting endothelial cells
at the animal and cellular levels. Our study showed that oxidative stress was significantly enriched in the endoplasmic
reticulum (ER). Thus, shikonin can effectively resist ER stress and inhibit inflammation and apoptosis of endothelial
cells. More importantly, we also found that shikonin can inhibit stress by regulating janus kinase2-signal transducers and
activators of transcription3 (JAK2/STAT3) pathways, thereby protecting endothelial cells from H2O2
-induced damage.
In addition, the application of shikonin to skin wounds in mice can also promote the expression of vascular endothelial
growth factor (VEGF) proteins in vascular endothelial cells; hence promoting the reconstruction of wounded blood
vessels and providing a proper blood supply, thus accelerating wound healing. In conclusion, our research findings
provide the groundwork for future clinical treatments of skin wounds and related research.
Download PDF
137 Downloads 744 Views
a |
Xinjiang Production & Construction Corps Key Laboratory of Protection and Utilization of Biological Resources in
Tarim Basin, College of Life Science and Technology, Tarim University, Xinjiang 843300 China |
b |
Department of Immunology, Nanjing Medical University, Jiangsu 211166 China |
c |
The First Affiliated Hospital of Nanjing Medical University, Jiangsu 211166 China |
d |
Department of Pharmacology, School of Basic Medical Science, Nanjing Medical University, Jiangsu 211166 China
|
e |
School of Basic Medical Science, Nanjing Medical University, Jiangsu 211166 China |
* Corresponding author, E-mail: zwe99@njmu.edu.cn, Tarim_yfzx406@126.com
Received 5 Oct 2022, Accepted 18 Mar 2023
|